Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305.6 INR | -1.15% | -1.66% | -3.44% |
Apr. 04 | Gufic Biosciences Forms New Wholly-Owned Arm in Dubai | MT |
Apr. 03 | Gufic Biosciences Limited Incorporates Wholly Owned Subsidiary Company in Dubai | CI |
Sales 2022 | 7.79B 93.21M | Sales 2023 | 6.91B 82.62M | Capitalization | 18.09B 216M |
---|---|---|---|---|---|
Net income 2022 | 958M 11.46M | Net income 2023 | 797M 9.53M | EV / Sales 2022 | 3.16 x |
Net Debt 2022 | 528M 6.31M | Net Debt 2023 | 3.06B 36.56M | EV / Sales 2023 | 3.06 x |
P/E ratio 2022 |
25.2
x | P/E ratio 2023 |
22.7
x | Employees | 1,628 |
Yield 2022 |
0.04% | Yield 2023 |
0.05% | Free-Float | 22.34% |
Latest transcript on Gufic Biosciences Limited
1 day | -1.15% | ||
1 week | -1.66% | ||
Current month | +8.16% | ||
1 month | +2.40% | ||
3 months | -9.79% | ||
6 months | +9.46% | ||
Current year | -3.44% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 41 | 04-06-24 | |
Chief Executive Officer | - | 99-08-30 | |
Director of Finance/CFO | - | 18-10-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 99-08-30 | |
Chief Executive Officer | 41 | 04-06-24 | |
Director/Board Member | 64 | 86-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 305.6 | -1.15% | 27,711 |
24-04-16 | 309.1 | +1.98% | 53,988 |
24-04-15 | 303.1 | -2.24% | 81,616 |
24-04-12 | 310 | -0.21% | 64,523 |
24-04-10 | 310.7 | -0.06% | 144,199 |
Delayed Quote NSE India S.E., April 18, 2024 at 07:43 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+27.97% | 676B | |
+23.58% | 554B | |
-7.02% | 349B | |
+14.85% | 318B | |
+6.25% | 291B | |
+2.96% | 210B | |
-0.41% | 204B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- GUFICBIO Stock
- GUFICBIO Stock